Interferon-Induced Protein 44 Interacts with Cellular FK506-Binding Protein 5, Negatively Regulates Host Antiviral Responses, and Supports Virus Replication

被引:65
|
作者
DeDiego, Marta L. [1 ,2 ,3 ]
Nogales, Aitor [2 ,4 ]
Martinez-Sobrido, Luis [2 ]
Topham, David J. [1 ,2 ]
机构
[1] Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA
[2] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14642 USA
[3] Univ Autonoma Madrid, Dept Mol & Cell Biol, CSIC, CNB, Madrid, Spain
[4] Ctr Anim Hlth Res INIA CISA, Madrid, Spain
来源
MBIO | 2019年 / 10卷 / 04期
基金
美国国家卫生研究院;
关键词
FKBP5; IFI44; IFN responses; antiviral responses; innate immunity; signaling transduction; virus-host interactions; NF-KAPPA-B; IKK-EPSILON; GENE-EXPRESSION; INNATE IMMUNITY; ALPHA; INDUCTION; PHOSPHORYLATION; UBIQUITINATION; ACTIVATION; IRF-3;
D O I
10.1128/mBio.01839-19
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Using multiple viral systems, and performing silencing approaches, overexpression approaches, and experiments in knockout cells, we report, for the first time, that interferon (IFN)-induced protein 44 (IFI44) positively affects virus production and negatively modulates innate immune responses induced after viral infections. Moreover, IFI44 is able to rescue poly(I.C)- and IFN-mediated inhibition of virus growth. Furthermore, we report a novel interaction of IFI44 with the cellular factor FK506-binding protein 5 (FKBP5), which binds to cellular kinases such as the inhibitor of nuclear factor kappa B (I kappa B) kinases (IKK alpha, IKK beta, and IKK epsilon). Importantly, in the presence of FKBP5, IFI44 decreases the ability of IKK beta to phosphorylate I kappa B alpha and the ability of IKK epsilon to phosphorylate interferon regulatory factor 3 (IRF-3), providing a novel mechanism for the function of IFI44 in negatively modulating IFN responses. Remarkably, these new IFI44 functions may have implications for diseases associated with excessive immune signaling and for controlling virus infections mediated by IFN responses. IMPORTANCE Innate immune responses mediated by IFN and inflammatory cytokines are critical for controlling virus replication. Nevertheless, exacerbated innate immune responses could be detrimental for the host and feedback mechanisms are needed to maintain the cellular homeostasis. In this work, we describe a completely novel function for IFI44 in negatively modulating the innate immune responses induced after viral infections. We show that decreasing IFI44 expression by using small interfering RNAs (siRNAs) or by generating knockout (KO) cells impairs virus production and increases the levels of IFN responses. Moreover, we report a novel interaction of IFI44 with the cellular protein FKBP5, which in turn interacts with kinases essential for type I and III IFN induction and signaling, such as the inhibitor of nuclear factor kappa B (I kappa B) kinases IKK alpha, IKK beta, and IKK epsilon. Our data indicate that binding of IFI44 to FKBP5 decreased the phosphorylation of IRF-3 and I kappa B alpha mediated by IKK epsilon and IKK beta, respectively, providing a likely explanation for the function of IFI44 in negatively modulating IFN responses. These results provide new insights into the induction of innate immune responses and suggest that IFI44 is a new potential antiviral target for reducing virus replication.
引用
收藏
页数:20
相关论文
共 8 条
  • [1] Interferon-Induced Protein 44 and Interferon-Induced Protein 44-Like Restrict Replication of Respiratory Syncytial Virus
    Busse, D. C.
    Habgood-Coote, D.
    Clare, S.
    Brandt, C.
    Bassano, I.
    Kaforou, M.
    Herberg, J.
    Levin, M.
    Eleouet, J. -F.
    Kellam, P.
    Tregoning, J. S.
    JOURNAL OF VIROLOGY, 2020, 94 (18)
  • [2] FK506-binding protein 5 regulates cell quiescence-proliferation decision in zebrafish epithelium
    Li, Yingxiang
    Liu, Chengdong
    Bai, Xuanxuan
    Li, Mingyu
    Duan, Cunming
    FEBS LETTERS, 2023, 597 (14) : 1868 - 1879
  • [3] Interferon-Inducible Protein IFI35 Negatively Regulates RIG-I Antiviral Signaling and Supports Vesicular Stomatitis Virus Replication
    Das, Anshuman
    Dinh, Phat X.
    Panda, Debasis
    Pattnaik, Asit K.
    JOURNAL OF VIROLOGY, 2014, 88 (06) : 3103 - 3113
  • [4] Influenza a virus NS1 protein induced A20 contributes to viral replication by suppressing interferon-induced antiviral response
    Feng, Wenjing
    Sun, Xiaoning
    Shi, Ning
    Zhang, Maolin
    Guan, Zhenhong
    Duan, Ming
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 482 (04) : 1107 - 1113
  • [5] Antiviral Effects of the Interferon-Induced Protein Guanylate Binding Protein 1 and Its Interaction with the Hepatitis C Virus NS5B Protein
    Itsui, Yasuhiro
    Sakamoto, Naoya
    Kakinuma, Sei
    Nakagawa, Mina
    Sekine-Osajima, Yuko
    Tasaka-Fujita, Megumi
    Nishimura-Sakurai, Yuki
    Suda, Gokui
    Karakama, Yuko
    Mishima, Kako
    Yamamoto, Machi
    Watanabe, Takako
    Ueyama, Mayumi
    Funaoka, Yusuke
    Azuma, Seishin
    Watanabe, Mamoru
    HEPATOLOGY, 2009, 50 (06) : 1727 - 1737
  • [6] Guanylate Binding Protein 4 Negatively Regulates Virus-Induced Type I IFN and Antiviral Response by Targeting IFN Regulatory Factor 7
    Hu, Yu
    Wang, Jie
    Yang, Bo
    Zheng, Nuoyan
    Qin, Meiling
    Ji, Yongyong
    Lin, Guomei
    Tian, Lin
    Wu, Xiaodong
    Wu, Li
    Sun, Bing
    JOURNAL OF IMMUNOLOGY, 2011, 187 (12) : 6456 - 6462
  • [7] Cellular poly(C) binding protein 2 interacts with porcine epidemic diarrhea virus papain-like protease 1 and supports viral replication
    Zhang, Pengfei
    Yu, Linyang
    Dong, Jianguo
    Liu, Yanling
    Zhang, Leyi
    Liang, Pengshuai
    Wang, Lei
    Chen, Bin
    Huang, Li
    Song, Changxu
    VETERINARY MICROBIOLOGY, 2020, 247
  • [8] In vitro characterization of the antiviral activity of Bat Interferon-Induced protein with tetratricopeptide repeats 5 (bat IFIT5) against bat-associated rabies virus
    Barboza, Camila Mosca
    Zamudio, Raphaela Mello
    Franco, Ana Claudia
    Batista, Helena Beatriz de Carvalho Ruthner
    JOURNAL OF NEUROVIROLOGY, 2025, : 163 - 169